Sign in

CIK 0001819576

  • Non-accelerated filer

Liquidia Corp

Sign in to watch
Ticker
LQDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851710962
Phone
+1 919-328-4400
Business address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
  1. 4 Grant or award Director acquired 18,396 shares (grant or award)
  2. 4 Grant or award Director acquired 18,396 shares (grant or award)
  3. 4 Grant or award Director acquired 18,396 shares (grant or award)
  4. 4 Grant or award Director acquired 18,396 shares (grant or award)
  5. 4 Planned sale General Counsel sold 8,460 shares at $16.97 ($143,566)
  6. 4 Planned sale Chief Commercial Officer sold 6,656 shares at $16.97 ($112,952)
  7. 4 Planned sale Chief Medical Officer sold 7,597 shares at $16.97 ($128,921)
  8. 4 Planned sale Chief Executive Officer sold 30,610 shares at $16.97 ($519,452)
  9. 4 Planned sale CFO and COO sold 14,777 shares at $16.97 ($250,766)
  10. 4 Planned sale Chief Business Officer sold 3,597 shares at $16.97 ($61,041)
  11. 4 Planned sale General Counsel sold 923 shares at $16.74 ($15,451)
  12. 4 Planned sale Chief Commercial Officer sold 581 shares at $16.74 ($9,726)
  13. 4 Planned sale CFO and COO sold 859 shares at $16.74 ($14,380)
  14. 4 Planned sale Chief Business Officer sold 451 shares at $16.74 ($7,550)
  15. 4 Planned sale Chief Business Officer sold 455 shares at $14.24 ($6,479)
  16. 4 Planned sale Chief Medical Officer sold 2,450 shares at $13.67 ($33,492)
  17. 4 Planned sale General Counsel sold 5,964 shares at $13.57 ($80,931)
  18. 4 Planned sale Chief Executive Officer sold 14,130 shares at $13.57 ($191,744)
  19. 4 Planned sale Chief Commercial Officer sold 3,406 shares at $13.57 ($46,219)
  20. 4 Planned sale CFO and COO sold 8,283 shares at $13.57 ($112,400)

Page 9 of 21 · 410 filings